Eating disorders in the 21st century: identification, management, and prevention in obstetrics and gynecology

被引:10
作者
Zerbe, Kathryn J. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Psychiat, Outpatient Serv, Portland, OR 97239 USA
关键词
anorexia; bulimia; co-morbidity; integrated treatment; screening; mortality; psychopharmacology; pregnancy;
D O I
10.1016/j.bpobgyn.2006.12.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Eating disorders are extremely common and carry a high degree of medical and psychiatric morbidity. These disorders are challenging to treat because many patients deny their symptoms, have poor motivation to change, and can become frustrating to the clinician. Case identification based upon suggested screening questions and ongoing management of medical consequences are important roles for the obstetrician/gynecologist involved in the care of these patients. This chapter discusses the benefits and limitations of contemporary treatment, special populations at risk (e.g. athletes, diabetics), and screening guidelines for office practice. Signs, symptoms, laboratory abnormalities, and the perils of associated psychiatric illness are briefly reviewed. Patients do respond to a comprehensive, integrated treatment plan that includes nutritional stabilization, psychotherapy, and pharmacotherapy. Collaboration between all professionals involved in the patient's care is essential for state-of-the-art care. Those patients who become pregnant or wish to become pregnant pose certain additional treatment considerations. Ongoing and future research aimed at understanding how eating disorders develop - and may be prevented by early identification and education - will result in enhanced knowledge of these life-threatening and often chronic illnesses in the 21st century.
引用
收藏
页码:331 / 343
页数:13
相关论文
共 58 条
[31]   Comorbidity of diabetes and eating disorders -: Does diabetes control reflect disturbed eating behavior? [J].
Herpertz, S ;
Albus, C ;
Wagener, R ;
Kocnar, M ;
Wagner, R ;
Henning, A ;
Best, F ;
Foerster, H ;
Schleppinghoff, BS ;
Thomas, W ;
Köhle, K ;
Mann, K ;
Senf, W .
DIABETES CARE, 1998, 21 (07) :1110-1116
[32]   Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa [J].
Kaye, WH ;
Nagata, T ;
Weltzin, TE ;
Hsu, LG ;
Sokol, MS ;
McConaha, C ;
Plotnicov, KH ;
Weise, J ;
Deep, D .
BIOLOGICAL PSYCHIATRY, 2001, 49 (07) :644-652
[33]  
LAESSLE RG, 1987, INT J EAT DISORDER, V6, P647, DOI 10.1002/1098-108X(198709)6:5<647::AID-EAT2260060508>3.0.CO
[34]  
2-H
[35]   Treating adolescents with eating disorders in the family context - Empirical and theoretical considerations [J].
Lock, J .
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 11 (02) :331-+
[36]  
MAJ M, 2003, EATING DISORDERS
[37]   Olanzapine treatment of anorexia nervosa: A retrospective study [J].
Malina, A ;
Gaskill, J ;
McConaha, C ;
Frank, GK ;
LaVia, M ;
Scholar, L ;
Kaye, WH .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2003, 33 (02) :234-237
[38]   Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases [J].
Mehler, C ;
Wewetzer, C ;
Schulze, U ;
Warnke, A ;
Theisen, F ;
Dittmann, RW .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2001, 10 (02) :151-157
[39]   Diagnosis and care of patients with anorexia nervosa in primary care settings [J].
Mehler, PS .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (11) :1048-1059
[40]   A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy [J].
Mitchell, JE ;
Agras, WS ;
Wilson, GT ;
Halmi, K ;
Kraemer, H ;
Crow, S .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2004, 35 (04) :549-555